Standard BioTools

是其中之一......

• Russell 3000;
• TOB Iconic 10,000.

Standard BioTools 是一家在股票代码 FLDM (US) 下上市的公司。

他们在：

• 医疗设备50%
• 生物技术50%

涉及Standard BioTools的并购和融资。

• Standard BioTools and SomaLogic have merged  (公布2024一月5号)..
• SomaLogic and Standard BioTools have announced they will merge  (公布2023十月6号)..

查看带有其 30 名主要高管的组织结构图

Standard BioTools 搜索最多的简介

• Michael Egholm, Chief Executive Officer and President
• Tom Carey, Chairman of the Board
• Fenel Eloi, Director

高管在Standard BioTools变化

• Alex Kim 曾任 Chief Operating Officer, 将于 20248月31 升职为 Chief Operating Officer and Interim Chief Financial Officer  (新闻发布的2024八月1号).
• Jeffrey Black, Senior Vice President and Chief Financial Officer, 将于 20248月30 退休  (新闻发布的2024八月1号).

创建提醒
跟踪 Standard BioTools 的高管变动

Standard BioTools 拥有 991 家竞争者，其中包括 Philips (荷兰)、Medtronic (爱尔兰岛) 和 Thermo Fisher Scientific (美国(美洲))。

Popular M&A news in 医疗设备

• ShiraTronics 刚刚宣布为 66 筹款数百万美元。 (公布2024十月23号).
• Johnson & Johnson 已收购 V-Wave (公布2024十月9号).
• Biolase Technology has filed for bankruptcy protection Biolase Technology  (公布2024十月2号).

医疗设备 行业的其他推荐联系人

• Medical Microinstruments 企业 Andrew Elbardissi - Director
• Illumina 企业 Frances Arnold - Director
• Intuitive Surgical 企业 Gary Guthart - President, Chief Executive Officer and Director

了解更多有关医疗设备行业的信息 >

Standard BioTools 的最新新闻稿

• Standard BioTools Announces Conference Call and Webcast of Second Quarter 2022 Financial Results | Standard BioTools Inc.
• Press Releases | Standard BioTools Inc.
• Standard BioTools Launches Hyperion+ Imaging System, the New Standard in High-Plex Spatial Imaging | Fluidigm Corporation
• Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Fluidigm Corporation
• Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc. | Fluidigm Corporation
• Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion | Fluidigm Corporation
• Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global | Fluidigm Corporation
• Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution | Fluidigm Corporation
• Fluidigm Adjourns Special Meeting of Stockholders Until April 1, 2022 | Fluidigm Corporation
• Fluidigm Urges Stockholders to Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion TODAY | Fluidigm Corporation
• View more press releases Close

关于 Standard BioTools 的社交媒体

• Standard BioTools 在 维基百科、谷歌新闻 和 雅虎财经
• Standard BioTools 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Michael Egholm

致电Standard BioTools，电话：+1 650...

查看组织结构图

Register to receive your alert

报告错误